185 related articles for article (PubMed ID: 9324622)
1. [Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases].
Schnabel A; Csernok E; Schultz H; Stoffel M; Herzberg C; Carroll SF; Gross WL
Med Klin (Munich); 1997 Jul; 92(7):389-93. PubMed ID: 9324622
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
3. ANCA against bactericidal/permeability-increasing protein, azurocidin, calprotectin and defensins in rheumatic and infectious diseases: prevalence and clinical associations.
Schultz H; Csernok E; Herlyn K; Reichel PH; Moosig F; Cornely OA; Fagerhol MK; Gross WL
Clin Exp Rheumatol; 2003; 21(6 Suppl 32):S117-20. PubMed ID: 14740437
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
5. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.
Stoffel MP; Csernok E; Herzberg C; Johnson T; Carroll SF; Gross WL
Clin Exp Immunol; 1996 Apr; 104(1):54-9. PubMed ID: 8603534
[TBL] [Abstract][Full Text] [Related]
6. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
Schinke S; Fellermann K; Herlyn K; Reichel PH; Fundke R; Stange EF; Gross WL; Schultz H
Inflamm Bowel Dis; 2004 Nov; 10(6):763-70. PubMed ID: 15626895
[TBL] [Abstract][Full Text] [Related]
8. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin.
Cooper T; Savige J; Nassis L; Paspaliaris B; Neeson P; Neil J; Knight KR; Daskalakis M; Doery JC
Rheumatol Int; 2000; 19(4):129-36. PubMed ID: 10836522
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
10. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
11. Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease.
Yang JJ; Tuttle R; Falk RJ; Jennette JC
Clin Exp Immunol; 1996 Jul; 105(1):125-31. PubMed ID: 8697620
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis.
Zhao MH; Jones SJ; Lockwood CM
Clin Exp Immunol; 1995 Jan; 99(1):49-56. PubMed ID: 7813109
[TBL] [Abstract][Full Text] [Related]
14. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Vecchi M; Sinico A; Bianchi MB; Radice A; Gionchetti P; Campieri M; de Franchis R
Scand J Gastroenterol; 1998 Dec; 33(12):1284-8. PubMed ID: 9930392
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.
Sedivá A; Bartůnková J; Kolárová I; Hrusák O; Vávrová V; Macek M; Lockwood CM; Dunn AC
J Autoimmun; 1998 Apr; 11(2):185-90. PubMed ID: 9650098
[TBL] [Abstract][Full Text] [Related]
16. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role.
Hertervig E; Wieslander J; Johansson C; Wiik A; Nilsson A
Scand J Gastroenterol; 1995 Jul; 30(7):693-8. PubMed ID: 7481534
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.
Audrain MA; Sesboüé R; Baranger TA; Elliott J; Testa A; Martin JP; Lockwood CM; Esnault VL
Nephrol Dial Transplant; 2001 Jan; 16(1):39-44. PubMed ID: 11208991
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation.
Esquivel-Valerio JA; Flores-Suárez LF; Rodríguez-Amado J; Garza-Elizondo MA; Rendón A; Salinas-Carmona MC
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):35-9. PubMed ID: 20412700
[TBL] [Abstract][Full Text] [Related]
19. Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.
Schultz H; Csernok E; Johnston TW; Lockwood CM; Gross WL
J Immunol Methods; 1997 Jul; 205(2):127-33. PubMed ID: 9294593
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]